Suppr超能文献

口服葛缕子对链脲佐菌素诱导的糖尿病大鼠体重、血糖及血脂的影响。

The effect of oral administration of Carum carvi on weight, serum glucose, and lipid profile in streptozotocin-induced diabetic rats.

作者信息

Haidari Fatemeh, Seyed-Sadjadi Neda, Taha-Jalali Mohammad, Mohammed-Shahi Majid

机构信息

Department of Nutrition, Nutrition Research Center, Ahvaz Jondi Shapour University of Medical Sciences, Ahvaz, Iran.

出版信息

Saudi Med J. 2011 Jul;32(7):695-700.

Abstract

OBJECTIVE

To evaluate the effect of oral administration of caraway (Carum carvi) on the blood glucose level, lipid profile, and the weight of diabetic rats.

METHODS

This investigation was carried out in Ahvaz University of Medical Sciences, Ahvaz, Iran between April and June 2010. Twenty-four male Wistar rats weighing 200-250 g were randomly divided into 3 groups: normal, diabetic, and caraway treated diabetic groups and were studied for 3 weeks. Diabetes was induced by intraperitoneal injection of 60 mg/kg body weight streptozotocin. Caraway was given orally at a dose of 1g/kg body weight daily, and the body weight of animals was measured every day. Blood samples were collected and blood glucose levels and lipid profile were determined.

RESULTS

The results showed that oral administration of caraway caused a significant decrease in blood glucose level of treated rats (p = 0.001) and alleviated their body weight loss (p = 0.037). Furthermore, it caused significant decrease in total cholesterol (p = 0.036), and low-density lipoprotein cholesterol levels (p = 0.001) in the treated animals compared with the diabetic control rats, and with no significant change in triglyceride and high-density lipoprotein cholesterol levels.

CONCLUSION

Caraway has both antihyperglycemic and hypolipidemic activity in diabetic rats. Nevertheless, it is not recommended before further investigations in animals and humans.

摘要

目的

评估口服葛缕子(Carum carvi)对糖尿病大鼠血糖水平、血脂谱及体重的影响。

方法

本研究于2010年4月至6月在伊朗阿瓦士医科大学进行。将24只体重200 - 250克的雄性Wistar大鼠随机分为3组:正常组、糖尿病组和葛缕子治疗糖尿病组,研究为期3周。通过腹腔注射60毫克/千克体重的链脲佐菌素诱导糖尿病。每天以1克/千克体重的剂量口服给予葛缕子,每天测量动物体重。采集血样并测定血糖水平和血脂谱。

结果

结果显示,口服葛缕子可使治疗组大鼠的血糖水平显著降低(p = 0.001),并减轻其体重减轻(p = 0.037)。此外,与糖尿病对照大鼠相比,它使治疗动物的总胆固醇(p = 0.036)和低密度脂蛋白胆固醇水平显著降低(p = 0.001),而甘油三酯和高密度脂蛋白胆固醇水平无显著变化。

结论

葛缕子对糖尿病大鼠具有降血糖和降血脂活性。然而,在对动物和人类进行进一步研究之前,不建议使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验